Ixepro is a commonly used immunological agent, mainly for patients with rheumatoid arthritis and ankylosing spondylitis, especially in the active stage of the disease, the treatment effect of Ixepro is relatively obvious, the general injection course is about four weeks, twice a week, generally applied for about four weeks, including moderate to severe rheumatoid arthritis symptoms, as well as The symptoms of rheumatoid arthritis and ankylosing spondylitis will be significantly relieved. Once the symptoms are relieved, the drug can be discontinued, mainly because this immune drug is likely to produce adverse reactions, the most common of which are infections, allergies, and the possibility of malignant tumors, and patients with sepsis, active tuberculosis infection, or severe allergies should not use this drug.